Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)
WITNESSES:
Canadian Drug Manufacturers Association:
Leslie Dan, Chairman and CEO, Novopharm Ltd.;
Brenda Drinkwalter, President;
Jim Keon, Vice-President, Research and International Affairs;
Joseph Kerba, Vice-President, Operations, Novopharm Quebec;
Barry Sherman, Chairman and CEO, Apotex Inc.